KPX Lifescience.Co.Ltd (114450) — Capital Reinvestment Ratio
KPX Lifescience.Co.Ltd (114450) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩3.33 Billion) in capital expenditures (₩275.98 Million). See how leveraged is KPX Lifescience.Co.Ltd's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
KPX Lifescience.Co.Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks KPX Lifescience.Co.Ltd's Capital Reinvestment Ratio across 10 annual periods. Check KPX Lifescience.Co.Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for KPX Lifescience.Co.Ltd from 2014 to 2024. For live market cap and broader valuation context, see 114450 company net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.88x | ₩525.49 Million | ₩462.71 Million | ▼ -31.4% |
| 2023 | 1.28x | ₩370.02 Million | ₩475.02 Million | ▼ -77.2% |
| 2021 | 5.63x | ₩611.38 Million | ₩3.44 Billion | ▲ +301.7% |
| 2020 | 1.40x | ₩1.90 Billion | ₩2.67 Billion | ▲ +65.2% |
| 2019 | 0.85x | ₩4.24 Billion | ₩3.60 Billion | ▼ -39.0% |
| 2018 | 1.39x | ₩5.38 Billion | ₩7.49 Billion | ▲ +83.6% |
| 2017 | 0.76x | ₩5.68 Billion | ₩4.31 Billion | ▲ +234.5% |
| 2016 | 0.23x | ₩7.07 Billion | ₩1.60 Billion | ▲ +141.7% |
| 2015 | 0.09x | ₩5.62 Billion | ₩526.82 Million | ▼ -54.3% |
| 2014 | 0.21x | ₩4.09 Billion | ₩838.78 Million | — |